z-logo
open-access-imgOpen Access
Bevacizumab is an effective treatment for symptomatic cerebral necrosis after carbon ion therapy for recurrent intracranial malignant tumours: A case report
Author(s) -
Ruifeng Liu,
Hui Luo,
Qiuning Zhang,
Shilong Sun,
Zhiqiang Liu,
Xiaohu Wang,
Yichao Geng,
Xueshan Zhao
Publication year - 2022
Publication title -
molecular and clinical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.442
H-Index - 7
eISSN - 2049-9469
pISSN - 2049-9450
DOI - 10.3892/mco.2022.2547
Subject(s) - bevacizumab , medicine , magnetic resonance imaging , radiology , cancer , chemotherapy , surgery

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here